ACUPUNCTURE

$ 125,005.10. $ 119,474.15. Acorn Biomedical Inc. Development of Adenosine A3 Receptor Antagoinst for the Treatment of Glaucoma. $ 172,773.37. $ 71,705.88. Act Biotech , Inc. Telatinib is a new cancer drug that can readily combine with chemotherapy. $ 244,479.25 ACT Biotech Inc. ACTB1003 a novel anti-cancer drug for treatment of cancers with ... ................
................